Key Takeaways  Rapid growth in regenerative and alternative therapies is expanding Healthcare Liability exposures across medspas and healthcare providers.  Coverage considerations are multifaceted, with many carriers applying exclusions, limitations, and strict underwriting requirements for therapies that are not approved by Health Canada or that are used outside their authorized indications. A complex regulatory environment, driven by federal and provincial oversight, impacts how Healthcare Liability risks are evaluated and underwritten.  …

